peer-reviewedExisting synthetic vascular grafts have unacceptably high failure rates when replacing below knee arteries. In vitro endothelialisation is an emerging procedure that has been shown to enhance the patency rates of below knee synthetic vascular grafts. Here autologous endothelial cells are harvested and cultured on the lining of the graft prior to implantation. The technique is limited by the narrow time frame availalble for culture and the finite cells obtainable following harvest. As well as this, existing synthetic materials are poor cellular substrates and must be combined with coatings to promote cellular growth and attachment. The most common coated graft used clinically is fibrin-coated polytetrafluoroethylene (ePT...
Survival of engineered tissues in vivo requires the presence of an internal vascular network and imm...
Tissue engineering has gained attention as an alternative approach for developing small diameter tis...
Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no gro...
peer-reviewedIntroduction Existing synthetic vascular grafts have unacceptably high failure rates w...
For small diameter (<6 mm) blood vessel replacements, lack of collaterals and vascular disease precl...
Pre-endothelialization of a tissue-engineered vascular graft before implantation aims to prevent thr...
Tissue engineering of small diameter (<5 mm) blood vessels is a promising approach to develop via...
Objective: Previous tissue engineering approaches to create small caliber vascular grafts have been ...
Coronary bypass graft failure as a result of acute thrombosis and intimal hyperplasia has been the m...
Self‐sustainability after implantation is one of the critical obstacles facing large engineered tiss...
Objective: Previous tissue engineering approaches to create small caliber vascular grafts have been ...
Failure of synthetic small-diameter vascular grafts is determined mainly by the lack of endothelial ...
The development of vascularized scaffolds remains one of the major challenges in tissue engineering,...
There is an ongoing clinical need for tissue-engineered small-diameter (<6 mm) vascular grafts since...
Developments in tissue engineering techniques have allowed for the creation of biocompatible, non-im...
Survival of engineered tissues in vivo requires the presence of an internal vascular network and imm...
Tissue engineering has gained attention as an alternative approach for developing small diameter tis...
Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no gro...
peer-reviewedIntroduction Existing synthetic vascular grafts have unacceptably high failure rates w...
For small diameter (<6 mm) blood vessel replacements, lack of collaterals and vascular disease precl...
Pre-endothelialization of a tissue-engineered vascular graft before implantation aims to prevent thr...
Tissue engineering of small diameter (<5 mm) blood vessels is a promising approach to develop via...
Objective: Previous tissue engineering approaches to create small caliber vascular grafts have been ...
Coronary bypass graft failure as a result of acute thrombosis and intimal hyperplasia has been the m...
Self‐sustainability after implantation is one of the critical obstacles facing large engineered tiss...
Objective: Previous tissue engineering approaches to create small caliber vascular grafts have been ...
Failure of synthetic small-diameter vascular grafts is determined mainly by the lack of endothelial ...
The development of vascularized scaffolds remains one of the major challenges in tissue engineering,...
There is an ongoing clinical need for tissue-engineered small-diameter (<6 mm) vascular grafts since...
Developments in tissue engineering techniques have allowed for the creation of biocompatible, non-im...
Survival of engineered tissues in vivo requires the presence of an internal vascular network and imm...
Tissue engineering has gained attention as an alternative approach for developing small diameter tis...
Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no gro...